Drug detox: Detox, short for detoxification, is the first phase in many substance abuse treatment programs. During detox, patients are monitored by professionals during their withdrawal from drugs. Medications, nutritional supplementation and fluid replacement may be provided to relieve withdrawal symptoms. At the same time, counseling is provided to encourage the patient to move forward to the next phase of rehabilitation.
One of the major benefits of limiting our enrolment is having the space for flexibility and individuality a larger institution can never accommodate. While our addiction treatment program is primarily focused on evidence-based psychotherapy, we are open and able to integrate into this whichever alternative therapies appeal to each resident. Our goal is to provide each of our residents with precisely the right combination of Psychological, Medical, Pharmaceutical, Nutritional, Alternative and Spiritual practices that will bring each of them their recovery. We pride ourselves in our ability to work with each resident closely, and offer him or her the care, support and treatment they need with compassion and dignity.
If you’re ready to face your addiction, make an appointment with your doctor. They will likely ask you a series of questions to determine your level of addiction. These questions can also help them determine which treatment option is best suited to your needs. They may also want to speak with some of your friends or relatives to gauge your addiction, symptoms, and treatment opportunities.
As with treatment for most substance abuse problems, there are two angles to treating an alcohol problem. The first step is to break the physical dependence on alcohol. As mentioned above, cutting off alcohol after developing an addiction to it can cause withdrawal symptoms that could be severe enough to drive a patient back to drinking. For that reason, the detoxification process of treatment often involves the careful administration of drugs like anti-anxiety drugs to help wean the patient off their dependence on alcohol and through the process of acclimatizing to life without alcohol.
Alcohol is considered safe in moderation, but when occasional use becomes more common and begins to interfere with everyday life, it is typically classed as abuse. The UK Government’s guidelines on alcohol consumption states that no more than fourteen units of alcohol should be consumed by adult men and women each week; which means that consuming a large amount at one time (binge drinking), may still be considered abuse, without it being a regular occurrence.
Addiction is a complex but treatable condition. It is characterized by compulsive drug craving, seeking, and use that persists even if the user is aware of severe adverse consequences. For some people, addiction becomes chronic, with periodic relapses even after long periods of abstinence. As a chronic, relapsing disease, addiction may require continued treatments to increase the intervals between relapses and diminish their intensity. While some with substance issues recover and lead fulfilling lives, others require ongoing additional support. The ultimate goal of addiction treatment is to enable an individual to manage their substance misuse; for some this may mean abstinence. Immediate goals are often to reduce substance abuse, improve the patient's ability to function, and minimize the medical and social complications of substance abuse and their addiction; this is called "harm reduction".
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)